vs
Enpro Inc.（NPO）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Enpro Inc.的季度营收约是REPLIGEN CORP的1.5倍（$295.4M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -10.8%，领先17.5%），Enpro Inc.同比增速更快（14.3% vs 13.6%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 7.1%）
Enpro是总部位于美国的工业技术企业，面向半导体、航空航天、发电、重卡、农业机械、化工处理、浆纸、生命科学等技术密集型领域设计生产专用产品及材料。公司在全球12个国家布局61个核心生产基地，下设密封技术、先进表面技术及工程技术三大业务板块。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
NPO vs RGEN — 直观对比
营收规模更大
NPO
是对方的1.5倍
$197.9M
营收增速更快
NPO
高出0.7%
13.6%
净利率更高
RGEN
高出17.5%
-10.8%
两年增速更快
RGEN
近两年复合增速
7.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $295.4M | $197.9M |
| 净利润 | $-32.0M | $13.3M |
| 毛利率 | 42.1% | 52.5% |
| 营业利润率 | 11.2% | 9.0% |
| 净利率 | -10.8% | 6.7% |
| 营收同比 | 14.3% | 13.6% |
| 净利润同比 | -330.2% | 143.9% |
| 每股收益（稀释后） | $-1.50 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NPORGEN
| Q4 25 | $295.4M | $197.9M | ||
| Q3 25 | $286.6M | $188.8M | ||
| Q2 25 | $288.1M | $182.4M | ||
| Q1 25 | $273.2M | $169.2M | ||
| Q4 24 | $258.4M | $174.1M | ||
| Q3 24 | $260.9M | $154.9M | ||
| Q2 24 | $271.9M | $154.1M | ||
| Q1 24 | $257.5M | $151.3M |
净利润NPORGEN
| Q4 25 | $-32.0M | $13.3M | ||
| Q3 25 | $21.6M | $14.9M | ||
| Q2 25 | $26.4M | $14.9M | ||
| Q1 25 | $24.5M | $5.8M | ||
| Q4 24 | $13.9M | $-30.3M | ||
| Q3 24 | $19.8M | $-654.0K | ||
| Q2 24 | $26.7M | $3.3M | ||
| Q1 24 | $12.5M | $2.1M |
毛利率NPORGEN
| Q4 25 | 42.1% | 52.5% | ||
| Q3 25 | 41.9% | 53.2% | ||
| Q2 25 | 43.3% | 50.0% | ||
| Q1 25 | 43.3% | 53.6% | ||
| Q4 24 | 42.3% | 26.1% | ||
| Q3 24 | 42.3% | 50.0% | ||
| Q2 24 | 43.8% | 49.8% | ||
| Q1 24 | 41.2% | 49.5% |
营业利润率NPORGEN
| Q4 25 | 11.2% | 9.0% | ||
| Q3 25 | 14.3% | 8.9% | ||
| Q2 25 | 15.9% | 7.6% | ||
| Q1 25 | 15.3% | 3.9% | ||
| Q4 24 | 12.5% | -17.7% | ||
| Q3 24 | 13.1% | -5.1% | ||
| Q2 24 | 17.7% | 1.0% | ||
| Q1 24 | 10.9% | 1.3% |
净利率NPORGEN
| Q4 25 | -10.8% | 6.7% | ||
| Q3 25 | 7.5% | 7.9% | ||
| Q2 25 | 9.2% | 8.2% | ||
| Q1 25 | 9.0% | 3.4% | ||
| Q4 24 | 5.4% | -17.4% | ||
| Q3 24 | 7.6% | -0.4% | ||
| Q2 24 | 9.8% | 2.2% | ||
| Q1 24 | 4.9% | 1.4% |
每股收益（稀释后）NPORGEN
| Q4 25 | $-1.50 | $0.24 | ||
| Q3 25 | $1.01 | $0.26 | ||
| Q2 25 | $1.25 | $0.26 | ||
| Q1 25 | $1.15 | $0.10 | ||
| Q4 24 | $0.65 | $-0.55 | ||
| Q3 24 | $0.94 | $-0.01 | ||
| Q2 24 | $1.27 | $0.06 | ||
| Q1 24 | $0.59 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $114.7M | $767.6M |
| 总债务越低越好 | $655.3M | $542.2M |
| 股东权益账面价值 | $1.5B | $2.1B |
| 总资产 | $2.7B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.42× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资NPORGEN
| Q4 25 | $114.7M | $767.6M | ||
| Q3 25 | $132.9M | $748.7M | ||
| Q2 25 | $107.1M | $708.9M | ||
| Q1 25 | $240.3M | $697.2M | ||
| Q4 24 | $236.3M | $757.4M | ||
| Q3 24 | $206.9M | $784.0M | ||
| Q2 24 | $175.9M | $809.1M | ||
| Q1 24 | $163.9M | $780.6M |
总债务NPORGEN
| Q4 25 | $655.3M | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $640.1M | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $644.9M | — |
股东权益NPORGEN
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.5B | $2.1B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.5B | $2.0B | ||
| Q4 24 | $1.4B | $2.0B | ||
| Q3 24 | $1.5B | $2.0B | ||
| Q2 24 | $1.4B | $2.0B | ||
| Q1 24 | $1.4B | $2.0B |
总资产NPORGEN
| Q4 25 | $2.7B | $2.9B | ||
| Q3 25 | $2.4B | $2.9B | ||
| Q2 25 | $2.4B | $2.9B | ||
| Q1 25 | $2.5B | $2.9B | ||
| Q4 24 | $2.5B | $2.8B | ||
| Q3 24 | $2.5B | $2.8B | ||
| Q2 24 | $2.5B | $2.9B | ||
| Q1 24 | $2.5B | $2.8B |
负债/权益比NPORGEN
| Q4 25 | 0.42× | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.45× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.46× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | 4.1% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流NPORGEN
| Q4 25 | — | $25.7M | ||
| Q3 25 | $65.3M | $48.1M | ||
| Q2 25 | $52.2M | $28.6M | ||
| Q1 25 | $21.0M | $15.0M | ||
| Q4 24 | $59.4M | $39.2M | ||
| Q3 24 | $54.0M | $49.3M | ||
| Q2 24 | $43.2M | $42.2M | ||
| Q1 24 | $6.3M | $44.7M |
自由现金流NPORGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | $53.4M | $43.4M | ||
| Q2 25 | $42.3M | $21.5M | ||
| Q1 25 | $13.0M | $11.4M | ||
| Q4 24 | $49.1M | $33.6M | ||
| Q3 24 | $48.3M | $42.3M | ||
| Q2 24 | $38.3M | $37.4M | ||
| Q1 24 | $-1.9M | $36.4M |
自由现金流率NPORGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | 18.6% | 23.0% | ||
| Q2 25 | 14.7% | 11.8% | ||
| Q1 25 | 4.8% | 6.8% | ||
| Q4 24 | 19.0% | 19.3% | ||
| Q3 24 | 18.5% | 27.3% | ||
| Q2 24 | 14.1% | 24.3% | ||
| Q1 24 | -0.7% | 24.0% |
资本支出强度NPORGEN
| Q4 25 | 4.1% | 4.1% | ||
| Q3 25 | 4.2% | 2.5% | ||
| Q2 25 | 3.4% | 3.9% | ||
| Q1 25 | 2.9% | 2.1% | ||
| Q4 24 | 4.0% | 3.2% | ||
| Q3 24 | 2.2% | 4.5% | ||
| Q2 24 | 1.8% | 3.1% | ||
| Q1 24 | 3.2% | 5.5% |
现金转化率NPORGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 3.02× | 3.23× | ||
| Q2 25 | 1.98× | 1.92× | ||
| Q1 25 | 0.86× | 2.57× | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | 2.73× | — | ||
| Q2 24 | 1.62× | 12.70× | ||
| Q1 24 | 0.50× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NPO
| Sealing Technologies Segment | $187.0M | 63% |
| General Industrial | $71.3M | 24% |
| Power Generation | $19.9M | 7% |
| Oiland Gas Market | $15.0M | 5% |
| Semiconductors | $2.2M | 1% |
RGEN
暂无分部数据
